The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Activation of PKA leads to mesenchymal-to-epithelial transition and loss of tumor-initiating ability
Open accessAbstract
Have cancer stem cells MET their match?: Solid tumors have been hypothesized to contain a subset of highly aggressive cells that fuel tumor growth and metastasis. The search is on for drugs that selectively kill or diminish the malignant properties of these tumor-initiating cells (TICs; previously called “cancer stem cells”). Pattabiraman et al. hypothesized that compounds that induce TICs to undergo a phenotypic change called the mesenchymal-to-epithelial transition (MET) would therefore cause TICs to lose their tumor-initiating ability. Indeed, drugs activating the protein kinase A signaling pathway triggered an epigenetic reprogramming of TICs that resulted in the cells acquiring a more benign epithelial-like phenotype. Science , this issue p. 10.1126/science.aad3680
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast gapped-read alignment with Bowtie 2
Langmead, B., & Salzberg, S. L. (2012) · Nature Methods · doi:10.1038/nmeth.1923 · Cited by 56,400
BEDTools: a flexible suite of utilities for comparing genomic features
Quinlan, A. R., & Hall, I. M. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq033 · Cited by 27,437
HTSeq—a Python framework to work with high-throughput sequencing data
Anders, S., Pyl, P. T., & Huber, W. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btu638 · Cited by 21,464
Model-based Analysis of ChIP-Seq (MACS)
Zhang, Y., Liu, T., Meyer, C. A., Eeckhoute, J., Johnson, D. S., Bernstein, B. E., Nusbaum, C., Myers, R. M., Brown, M., Li, W., et al. (2008) · Genome Biology · doi:10.1186/gb-2008-9-9-r137 · Cited by 18,386
Differential expression analysis for sequence count data
Anders, S., & Huber, W. (2010) · Genome Biology · doi:10.1186/gb-2010-11-10-r106 · Cited by 15,581
Robinson, J. T., Thorvaldsdóttir, H., Winckler, W., Guttman, M., Lander, E. S., Getz, G., & Mesirov, J. P. (2011) · Nature Biotechnology · doi:10.1038/nbt.1754 · Cited by 15,390
Kim, D., Pertea, G., Trapnell, C., Pimentel, H., Kelley, R., & Salzberg, S. L. (2013) · Genome Biology · doi:10.1186/gb-2013-14-4-r36 · Cited by 12,668
Prospective identification of tumorigenic breast cancer cells
Al‐Hajj, M., Wicha, M. S., Benito‐Hernández, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,579
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M. W., Reinhard, F., Zhang, C. C., Shipitsin, M. V., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,839
Self-citationRegulatory networks defining EMT during cancer initiation and progression
Craene, B. D., & Berx, G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3447 · Cited by 2,487
Cited by
Sorted by citations
Items 101–200 of 332
Yang, S., Zhang, D., Sun, Q., Nie, H., Zhang, Y., Wang, X., Huang, Y., & Sun, Y. (2024) · Cancer Research · doi:10.1158/0008-5472.can-23-3264 · Cited by 54
SUV420H2 is an epigenetic regulator of epithelial/mesenchymal states in pancreatic cancer
Viotti, M., WILSON, C. A., McCleland, M. L., Koeppen, H., Haley, B., Jhunjhunwala, S., Klijn, C. N., Modrusan, Z. D., Arnott, D. P., Classon, M., et al. (2017) · The Journal of Cell Biology · doi:10.1083/jcb.201705031 · Cited by 49
Liu, J., Smith, S., & Wang, C. (2023) · Nano Letters · doi:10.1021/acs.nanolett.3c00089 · Cited by 48
Jacob, F., Alam, S., Konantz, M., Liang, C.-Y., Kohler, R. S., Everest‐Dass, A., Huang, Y., Rimmer, N., Fedier, A., Schötzau, A., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-2223 · Cited by 48
Watanabe, K., Liu, Y., Noguchi, S., Murray, M., Chang, J.-C., Kishima, M., Nishimura, H., Hashimoto, K., Minoda, A., & Suzuki, H. (2019) · Scientific Reports · doi:10.1038/s41598-019-43021-z · Cited by 50
Hoy, J. J., Parra, N. S., Park, J., Kuhn, S. A., & Iglesias‐Bartolomé, R. (2020) · The FASEB Journal · doi:10.1096/fj.202001515r · Cited by 46
Targeting Cancer Cell Metastasis by Converting Cancer Cells into Fat
Ishay-Ronen, D., & Christofori, G. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-1242 · Cited by 47
Transcriptional regulation of PRKAR2B by miR-200b-3p/200c-3p and XBP1 in human prostate cancer
Xia, L., Han, Q., Chi, C., Zhu, Y., Pan, J., Dong, B., Huang, Y., Xia, W., Xue, W., & Sha, J. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.109863 · Cited by 46
The role of A-kinase anchoring proteins in cancer development
Reggi, E., & Diviani, D. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.09.011 · Cited by 46
Targeting LRP8 inhibits breast cancer stem cells in triple-negative breast cancer
Lin, C.-C. A., Lo, M., Moody, R., Jiang, H., Harouaka, R. A., Stevers, N. O., Tinsley, S. L., Gasparyan, M., Wicha, M. S., & Sun, D. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.09.022 · Cited by 46
Functional characterization of AMP-activated protein kinase signaling in tumorigenesis
Cheng, J., Zhang, T., Ji, H., Tao, K., Guo, J., & Wei, W. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.09.006 · Cited by 45
Zheng, L., Zhang, Z., Zhang, S., Guo, Q., Zhang, F., Gao, L., Ni, H., Guo, X., Xiang, C., & Xi, T. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b01123 · Cited by 44
Illiano, M., Sapio, L., Salzillo, A., Capasso, L., Caiafa, I., Chiosi, E., Spina, A., & Naviglio, S. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.03.023 · Cited by 43
Aphthous ulcer drug inhibits prostate tumor metastasis by targeting IKKɛ/TBK1/NF-κB signaling
Cheng, C., Ji, Z., Sheng, Y., Wang, J., Sun, Y., Zhao, H., Li, X., Wang, X., He, Y., Yao, J., et al. (2018) · Theranostics · doi:10.7150/thno.26687 · Cited by 43
Targeting Adenylate Cyclase Family: New Concept of Targeted Cancer Therapy
Guo, R., Liu, T., Shasaltaneh, M. D., Wang, X., İmani, S., & Wen, Q. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.829212 · Cited by 42
FRA-1 as a Regulator of EMT and Metastasis in Breast Cancer
Casalino, L., Talotta, F., Matino, I., & Verde, P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098307 · Cited by 45
Phosphodiesterase 7B/microRNA-200c relationship regulates triple-negative breast cancer cell growth
Zhang, D., Li, Y., Xu, Y., Kim, J., & Huang, S. (2018) · Oncogene · doi:10.1038/s41388-018-0499-2 · Cited by 42
EMT-induced immune evasion: connecting the dots from mechanisms to therapy
Imodoye, S. O., & Adedokun, K. A. (2023) · Clinical and Experimental Medicine · doi:10.1007/s10238-023-01229-4 · Cited by 44
Cellular Phenotype Plasticity in Cancer Dormancy and Metastasis
Yang, X., Liang, X., Zheng, M. H., & Tang, Y. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00505 · Cited by 42
Lung endothelium exploits susceptible tumor cell states to instruct metastatic latency
Jakab, M., Lee, K. H., Uvarovskii, A., Ovchinnikova, S., Kulkarni, S. R., Jakab, S., Rostalski, T., Spegg, C., Anders, S., & Augustin, H. G. (2024) · Nature Cancer · doi:10.1038/s43018-023-00716-7 · Cited by 39
cAMP/EPAC Signaling Enables ETV2 to Induce Endothelial Cells with High Angiogenesis Potential
Kim, J.-J., Kim, D., Lee, J. Y., Lee, B., Kang, I., Kook, M. G., Kong, D., Choi, S. W., Woo, H., Kim, D., et al. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.11.019 · Cited by 39
Ahmad, J. N., Holubova, J., Benada, O., Kofronova, O., Stehlik, L., Vasakova, M., & Sebo, P. (2019) · mBio · doi:10.1128/mbio.01743-19 · Cited by 38
Breast cancer stem cells as last soldiers eluding therapeutic burn: A hard nut to crack
Nilendu, P., Kumar, A., Kumar, A., Pal, J. K., & Sharma, N. K. (2017) · International Journal of Cancer · doi:10.1002/ijc.30898 · Cited by 38
PDE5 inhibition eliminates cancer stem cells via induction of PKA signaling
Klutzny, S., Anurin, A., Nicke, B., Regan, J. L., Lange, M., Schulze, L., Parczyk, K., & Steigemann, P. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0202-5 · Cited by 37
GALNT3 Maintains the Epithelial State in Trophoblast Stem Cells
Raghu, D., Mobley, R. J., Shendy, N. A. M., Perry, C. H., & Abell, A. N. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.02.093 · Cited by 37
Shi, H., Sun, X., Kong, A., Ma, H., Xie, Y., Cheng, D., Wong, C. K. C., Zhou, Y., & Gu, J. (2020) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2020.111480 · Cited by 37
Gallardo, A., Molina, A., Asenjo, H. G., López-Onieva, L., Martorell‐Marugán, J., Espinosa-Martínez, M., Griñán‐Lisón, C., Álvarez-Pérez, J. C., Cara, F. E., Navarro-Marchal, S. A., et al. (2022) · Oncogene · doi:10.1038/s41388-022-02375-x · Cited by 39
Engaging plasticity: Differentiation therapy in solid tumors
Bar-Hai, N., & Ishay-Ronen, D. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.944773 · Cited by 35
Reactivation of embryonic genetic programs in tissue regeneration and disease
Fazilaty, H., & Basler, K. (2023) · Nature Genetics · doi:10.1038/s41588-023-01526-4 · Cited by 43
The cancer stem cell phenotype as a determinant factor of the heterotypic nature of breast tumors
Fonseca, N. A., Cruz, A. F., Moura, V., Simões, S., & Moreira, J. N. (2017) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2017.03.016 · Cited by 36
The Complexities of Metastasis
Juan, B. P. S., García-León, M. J., Rangel, L., Goetz, J. G., & Chaffer, C. L. (2019) · Cancers · doi:10.3390/cancers11101575 · Cited by 35
He, X., Han, S., Li, X.-H., Zheng, W., Pang, L., Jiang, S., & Li, P. (2017) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2017.04.008 · Cited by 34
Grainyhead-like-2 confers NK-sensitivity through interactions with epigenetic modifiers
MacFawn, I., Wilson, H. E., Selth, L. A., Leighton, I. A., Serebriiskii, I. G., Bleackley, R. C., Elzamzamy, O. M., Farris, J. C., Pifer, P. M., Richer, J. K., et al. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2018.11.006 · Cited by 29
Yu, F., Mu, J., Huang, M., İmani, S., Wang, Y., Lin, S., Fan, J., & Wen, Q. (2019) · Epigenomics · doi:10.2217/epi-2019-0207 · Cited by 34
Na, Y. R., Kwon, J. W., Kim, D.-Y., Chung, H., Song, J., Jung, D., Quan, H., Kim, D., Kim, J., Ju, Y. W., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107643 · Cited by 35
Darbeheshti, F., Zokaei, E., Mansoori, Y., Allahyari, S. E., Kamaliyan, Z., Kadkhoda, S., Tavakkoly‐Bazzaz, J., Rezaei, N., & Shakoori, A. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02015-6 · Cited by 34
Contribution of adrenergic mechanisms for the stress‐induced breast cancer carcinogenesis
Silva, D., Quintas, C., Gonçalves, J., & Fresco, P. (2022) · Journal of Cellular Physiology · doi:10.1002/jcp.30707 · Cited by 38
Rerouting mesenchymal stem cell trajectory towards epithelial lineage by engineering cellular niche
Barui, A., Chowdhury, F., Pandit, A. S., & Datta, P. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.11.036 · Cited by 34
Hodge, D. Q., Cui, J., Gamble, M. J., & Guo, W. (2018) · Scientific Reports · doi:10.1038/s41598-018-19364-4 · Cited by 34
BRMS1: a multifunctional signaling molecule in metastasis
Zimmermann, R. C., & Welch, D. R. (2020) · Cancer and Metastasis Reviews · doi:10.1007/s10555-020-09871-0 · Cited by 35
Liu, Y., Chen, T., Guo, M., Li, Y., Zhang, Q., Tan, G., Yu, L., & Tan, Y. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.605025 · Cited by 31
Nowicki, A., Kulus, M., Wieczorkiewicz, M., Pieńkowski, W., Stefańska, K., Skupin-Mrugalska, P., Bryl, R., Mozdziak, P. E., Kempisty, B., & Piotrowska‐Kempisty, H. (2021) · Cancers · doi:10.3390/cancers13164178 · Cited by 31
FBXO28 suppresses liver cancer invasion and metastasis by promoting PKA-dependent SNAI2 degradation
Qiao, X., Lin, J., Shen, J., Yang, C., Zheng, L., Ren, H., Zhao, X., Yang, H., Li, P., & Wang, Z. (2023) · Oncogene · doi:10.1038/s41388-023-02809-0 · Cited by 31
Nanomedicine-mediated drug targeting of cancer stem cells
Singh, D., Minz, A. P., & Sahoo, S. K. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.04.005 · Cited by 31
Li, X., Zhao, Z., Zhang, X., Yang, S., Lin, X., Yang, X., Lin, X., Shi, J., Wang, S., Zhao, W., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.21370 · Cited by 30
Zhang, W., Zhou, P., Ai, M., Zhang, R., & Zhou, Y. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13455 · Cited by 30
Luan, M., Chang, J., Pan, W., Chen, Y., Li, N., & Tang, B. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b02494 · Cited by 31
Singh, D., Mohapatra, P., Kumar, S., Behera, S., Dixit, A., & Sahoo, S. K. (2021) · Toxicology in Vitro · doi:10.1016/j.tiv.2021.105293 · Cited by 31
Small-molecule inhibitors of histone deacetylase improve CRISPR-based adenine base editing
Shin, H. R., See, J.-E., Kweon, J., Kim, H. S., Sung, G., Park, S., Jang, A.-H., Jang, G., Choi, K., Kim, I., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab052 · Cited by 29
Kubiak, A., Chighizola, M., Schulte, C., Bryniarska, N., Wesołowska, J., Pudełek, M., Lasota, M., Ryszawy, D., Basta‐Kaim, A., Laidler, P. M., et al. (2021) · Nanoscale · doi:10.1039/d0nr06464e · Cited by 29
Lineage Plasticity in Cancer: The Tale of a Skin-Walker
Thankamony, A. P., Subbalakshmi, A. R., Jolly, M. K., & Nair, R. (2021) · Cancers · doi:10.3390/cancers13143602 · Cited by 28
Quinn, S., Graves, S. H., Dains‐McGahee, C., Fechter, E. F., Hassan, H., Witkowski, P., & Sabbatini, M. E. (2016) · Molecular Carcinogenesis · doi:10.1002/mc.22598 · Cited by 29
Aggarwal, S., Gabrovsek, L., Langeberg, L. K., Golkowski, M. G., Ong, S., Smith, F. D., & Scott, J. D. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006741 · Cited by 30
Alternative proteins are functional regulators in cell reprogramming by PKA activation
Cardon, T., Franck, J., Coyaud, É., Laurent, E. M. N., D’Amato, M., Maffia, M., Vergara, D., Fournier, I., & Salzet, M. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa277 · Cited by 30
Kawabata, H., Ono, Y., Tamamura, N., Oyama, K., Ueda, J., Sato, H., Takahashi, K., Taniue, K., Okada, T., Fujibayashi, S., et al. (2022) · Journal of Gastroenterology · doi:10.1007/s00535-021-01846-4 · Cited by 28
New Advances and Challenges of Targeting Cancer Stem Cells
Dashzeveg, N. K., Taftaf, R., Ramos, E. K., Torre-Healy, L. A., Chumakova, A. P., Silver, D. J., Alban, T. J., Sinyuk, M., Thiagarajan, P. S., Jarrar, A., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0054 · Cited by 27
Dihydroartemisinin inhibits the migration of esophageal cancer cells by inducing autophagy
Chen, X., He, L., Lai, S., & He, Y. (2020) · Oncology Letters · doi:10.3892/ol.2020.11955 · Cited by 27
Wang, W. J., Li, Y., Zhu, J. Y., Fang, D., Ding, H., Dong, Z., Jing, Q., Su, S., & Huang, S. (2016) · Oncotarget · doi:10.18632/oncotarget.13601 · Cited by 27
Hashimoto, Y., Kinoshita, N., Greco, T. M., Federspiel, J. D., Beltran, P. M. J., Ueno, N., & Cristea, I. M. (2019) · Cell Systems · doi:10.1016/j.cels.2019.01.006 · Cited by 24
Bhat‐Nakshatri, P., Gao, H., Khatpe, A. S., Adebayo, A. K., McGuire, P. C., Erdoğan, C., Chen, D., Jiang, G., New, F., German, R., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-03011-9 · Cited by 26
Connexin43 Suppresses Lung Cancer Stem Cells
Ruch, R. J. (2019) · Cancers · doi:10.3390/cancers11020175 · Cited by 26
Sakakitani, S., Podyma‐Inoue, K. A., Takayama, R., Takahashi, K., Ishigami‐Yuasa, M., Kagechika, H., Harada, H., & Watabe, T. (2020) · Cancer Science · doi:10.1111/cas.14670 · Cited by 25
Nanosized Drug Delivery Systems for Breast Cancer Stem Cell Targeting
Lv, L., Shi, Y., Wu, J., & Li, G. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s282110 · Cited by 26
Singh, D., Singh, P., Pradhan, A., Srivastava, R., & Sahoo, S. K. (2021) · ACS Applied Bio Materials · doi:10.1021/acsabm.1c00141 · Cited by 26
Placenta-specific protein 1 promotes cell proliferation and invasion in non-small cell lung cancer
Yang, L., Zha, T., He, X. F., Chen, L., Zhu, Q., Wu, W., Nie, F., Wang, Q., Zang, C., Zhang, M., et al. (2017) · Oncology Reports · doi:10.3892/or.2017.6086 · Cited by 26
Villemin, J.-P., Lorenzi, C., Oldfield, A., Cabrillac, M.-S., Ritchie, W., & Luco, R. F. (2021) · BMC Biology · doi:10.1186/s12915-021-01002-7 · Cited by 25
The landscape of GPCR signaling in the regulation of epidermal stem cell fate and skin homeostasis
Pedro, M. P., Lund, K., & Iglesias‐Bartolomé, R. (2020) · Stem Cells · doi:10.1002/stem.3273 · Cited by 25
Ungefroren, H., Thürling, I., Färber, B., Kowalke, T., Fischer, T., de Assis, L. V. M., Braun, R., Castven, D., Oster, H., Konukiewitz, B., et al. (2022) · Cancers · doi:10.3390/cancers14092057 · Cited by 25
Shagieva, G. S., Domnina, L. V., Makarevich, O. A., Chernyak, B. V., Skulachev, V. P., & Dugina, V. B. (2016) · Oncotarget · doi:10.18632/oncotarget.13612 · Cited by 25
Ognjenovic, N. B., Bagheri, M., Mohamed, G. A., Xu, K., Chen, Y., Saleem, M.-A. M., Brown, M. S., Nagaraj, S. H., Muller, K. E., Gerber, S. A., et al. (2020) · Developmental Cell · doi:10.1016/j.devcel.2020.10.004 · Cited by 24
Self-citationIlliano, M., Conte, M., Sapio, L., Nebbioso, A., Spina, A., Altucci, L., & Naviglio, S. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00792 · Cited by 24
The Journey of Cancer Cells to the Brain: Challenges and Opportunities
Łazarczyk, M., Mickael, M., Skiba, D. S., Kurzejamska, E., Ławiński, M., Horbańczuk, J. O., Radziszewski, J., Fraczek, K., Wolińska, R., Paszkiewicz, J., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043854 · Cited by 22
Wu, H., Binbin, J., Wei, Y., & Kun, Y. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.561669 · Cited by 22
Popęda, M., Stokowy, T., Bednarz‐Knoll, N., Jurek, A., Niemira, M., Bielska, A., Kretowski, A. J., Kalinowski, L., Szade, J., Markiewicz, A., et al. (2019) · Cancers · doi:10.3390/cancers11121961 · Cited by 22
Okada, N., Ueki, C., Shimazaki, M., Tsujimoto, G., Kohno, S., Muranaka, H., Yoshikawa, K., & Takahashi, C. (2023) · Communications Biology · doi:10.1038/s42003-023-04987-9 · Cited by 21
McCann, T. S., Sobral, L. M., Self, C., Hsieh, J. C. Y., Sechler, M., & Jedlicka, P. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1580692 · Cited by 21
Chemically induced cell fate reprogramming and the acquisition of plasticity in somatic cells
Zhao, Y. (2019) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2019.04.025 · Cited by 20
Zhang, J., Thorikay, M., van der Zon, G., van Dinther, M., & ten Dijke, P. (2020) · Journal of Visualized Experiments · doi:10.3791/61830 · Cited by 21
Liu, J., Jing, W., Wang, T., Hu, Z., & Lu, H. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106554 · Cited by 21
A coronaviral pore-replicase complex links RNA synthesis and export from double-membrane vesicles
Chen, A., Lupan, A., Quek, R. T., Stanciu, S. G., Asaftei, M., Stanciu, G. A., Hardy, K. S., Magalhães, T. D. A., Silver, P. A., Mitchison, T. J., et al. (2024) · Science Advances · doi:10.1126/sciadv.adq9580 · Cited by 20
Breast Cancer: A Molecular and Redox Snapshot
Raman, D., Foo, C. H. J., Clement, M., & Pervaiz, S. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6546 · Cited by 20
Chemokine/GPCR Signaling-Mediated EMT in Cancer Metastasis
Tian, X., Wang, J., Jiang, L., Jiang, Y., Xu, J., & Feng, X. (2022) · Journal of Oncology · doi:10.1155/2022/2208176 · Cited by 19
Salzillo, A., Ragone, A., Spina, A., Naviglio, S., & Sapio, L. (2023) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2023.151292 · Cited by 19
Fueling HCC Dynamics: Interplay Between Tumor Microenvironment and Tumor Initiating Cells
Huang, H., Tsui, Y., & Ng, I. O. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.01.007 · Cited by 19
Bagheri, M., Mohamed, G. A., Saleem, M. A. M., Ognjenovic, N. B., Lu, H., Kolling, F., Wilkins, O. M., Das, S., LaCroix, I. S., Nagaraj, S. H., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101504 · Cited by 19
Self-citationLi, Y., Song, J., Tong, Y., Chung, S. K., & Wong, Y. H. (2017) · Oncotarget · doi:10.18632/oncotarget.19509 · Cited by 18
Plant homeodomain finger protein 2 as a novel IKAROS target in acute lymphoblastic leukemia
Ge, Z., Gu, Y. H., Han, Q., Sloane, J., Ge, Q., Gao, G., Ma, J., Song, H., Hu, J., Chen, B., et al. (2017) · Epigenomics · doi:10.2217/epi-2017-0092 · Cited by 18
New Directions in the Study and Treatment of Metastatic Cancer
Yoo, B., Fuchs, B. C., & Medarova, Z. O. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00258 · Cited by 18
Ji, S., Deng, H., Jin, W., Yan, P., Wang, R., Pang, L., Zhou, J., Zhang, J., Chen, X., Zhao, X., et al. (2016) · FEBS Open Bio · doi:10.1002/2211-5463.12182 · Cited by 18
The Landscape of Circulating Tumor Cell Research in the Context of Epithelial-Mesenchymal Transition
Markiewicz, A., & Zaczek, A. J. (2017) · Pathobiology · doi:10.1159/000477812 · Cited by 15
Bhatt, A. B., Gupta, M., Hoang, V. T., Chakrabarty, S., Wright, T. D., Elliot, S., Chopra, I., Monlish, D. A., Anna, K., Burow, M. E., et al. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00672 · Cited by 17
Francisco, A. B., Kanke, M., Massa, A. P., Dinh, T. A., Sritharan, R., Vakili, K., Bardeesy, N. M., & Sethupathy, P. (2022) · JCI Insight · doi:10.1172/jci.insight.154743 · Cited by 16
Liu, M., Di, J., Liu, Y., Su, Z., Jiang, B., Wang, Z., & Su, X. (2018) · Cancer Biology & Therapy · doi:10.1080/15384047.2018.1456605 · Cited by 16
Anbalagan, M., Sheng, M., Fleischer, B. P., Zhang, Y., Gao, Y., Hoang, V., Matossian, M. D., Burks, H. E., Burow, M. E., Collins‐Burow, B. M., et al. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0297-t · Cited by 16
Edmond Fischer's kinase legacy: History of the protein kinase inhibitor and protein kinase A
Taylor, S. S., Herberg, F. W., Veglia, G., & Wu, J. (2023) · IUBMB Life · doi:10.1002/iub.2714 · Cited by 15
Chauhan, P. S., Alahi, I., Sinha, S. D., Ledet, E. M., Mueller, R., Linford, J., Shiang, A. L., Webster, J. B., Greiner, L. J., Yang, B., et al. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-24-1658 · Cited by 18
Regulation of KLF4 by posttranslational modification circuitry in endocrine resistance
Zhou, Z., Song, X., Chi, J. J., Gius, D. R., Huang, Y., Cristofanilli, M., & Wan, Y. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109574 · Cited by 15
Walen, K. H. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.12.023 · Cited by 15
Famta, P., Shah, S., Dey, B., Kumar, K. C., Bagasariya, D., Vambhurkar, G. B., Pandey, G., Sharma, A., Srinivasarao, D. A., Kumar, R., et al. (2024) · Cancer Pathogenesis and Therapy · doi:10.1016/j.cpt.2024.01.001 · Cited by 14
Ye, Z., Cheng, P., Huang, Q., Hu, J., Huang, L., & Hu, G. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1388176 · Cited by 15
Metadata
- Authors
- Pattabiraman, D. R., Bierie, B., Kober, K. I., Thiru, P., Krall, J. A., Zill, C., Reinhardt, F., Tam, W. L., & Weinberg, R. A.
- Affiliations
- Whitehead Institute for Biomedical Research (US)
- Corresponding author
- Weinberg, Robert A.
- ORCID
- Venue
- Science
- Published
- 2016-03-04
- Volume
- 351
- Issue
- 6277
- Pages
- aad3680-aad3680
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC5131720
- OpenAlex
- W2289283229
- Cited by
- 332
- References
- 60
- Citations by year
- 2026: 13 · 2025: 15 · 2024: 32 · 2023: 26 · 2022: 35 · 2021: 36 · 2020: 47 · 2019: 32 · 2018: 36 · 2017: 41 · 2016: 18
- FWCI
- 22.81
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-sa)
- PMC
- Funders
- National Health and Medical Research Council of Australia (NHMRC APP1071853)
- National Research Foundation, Singapore (NRF-NRFF2015-04)
- National Medical Research Council, Singapore (NMRC/TCR/007-NCC/2013)
- Ludwig Center for Molecular Oncology at MIT
- Breast Cancer Research Foundation
- Samuel Waxman Cancer Research Foundation
- NIH (R01-CA078461)
- American Cancer Society
- D. K. Ludwig Foundation Cancer Research
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Keywords
- protein kinase A, mesenchymal-epithelial transition, cancer stem cells, PHF2, histone demethylase, epigenetic reprogramming, cAMP signaling, mammary epithelial cells, differentiation therapy
- MeSH terms
- Adenosine Monophosphate, Animals, Breast Neoplasms, Cell Transformation, Neoplastic, Cholera Toxin, Enzyme Activation, Epithelial Cells, Female, Colforsin, Humans, Mesoderm, Neoplastic Stem Cells, Second Messenger Systems, Cyclic AMP-Dependent Protein Kinases, Homeodomain Proteins, Xenograft Model Antitumor Assays, Mammary Glands, Human, Epigenesis, Genetic, Cell Line, Tumor, Mice, Histone Demethylases, Epithelial-Mesenchymal Transition
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review